Companies › IRD

OPUS GENETICS INC (IRD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001228627 · EDGAR filings · Updated 2026-07-27

OPUS GENETICS INC (IRD) has reported institutional ownership of 63.8%, with 79 institutional managers holding positions valued at $203.7M per the latest 13F reporting period.

Filings this week (6)

• 2026-07-27 — Insider transaction reported (Form 4)
• 2026-07-27 — Insider transaction reported (Form 4)
• 2026-07-27 — Insider transaction reported (Form 4)
• 2026-07-27 — Insider transaction reported (Form 4)
• 2026-07-23 — Notice of proposed sale filed (Form 144)
• 2026-07-23 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, OPUS GENETICS INC has 79 institutional holders and institutional ownership of 63.8%.

Insider activity

Insiders reported 36 transactions (2 buys, 5 sells) across 15 reporting insiders, with a net reported value of −$8.46M.

Related companies

FOGHORN THERAPEUTICS INC (FHTX) · NAUTILUS BIOTECHNOLOGY INC (NAUT) · KEROS THERAPEUTICS INC (KROS) · OCUGEN INC COM (OCGN) · ATRIUM THERAPEUTICS INC (RNA) · CONTEXT THERAPEUTICS INC (CNTX)